title: Non Hodgkin's lymphoma with cutaneous involvement in AIDS patients: report of five cases and review of the literature.
abstract: Cutaneous B cell lymphoma (CBCL) is a lymphoproliferative disorder of neoplastic B cell of the skin with a wide range of clinical manifestations. Commonly, the clinical features of CBCL are plaques, nodules, or ulcerative lesions. Skin is one of the common sites for extra-nodal lymphomas in patients with AIDS and B cell type is less common than T cell type. Only recently, the existence of B cell lymphomas presenting clinically in the skin without evidence of extra-cutaneous involvement has been accepted as primary CBCL. Here, we are presenting 5 patients with cutaneous involvement in the setting of HIV/AIDS disease. Two of them were primary cutaneous non-Hodgkin lymphomas. All were CBCL; 3 were immunoblastic, 1 was plasmablastic, and the other was a Burkitt lymphoma. We analyzed the epidemiological, clinical, virological, and immunological characteristics of this group of patients.
authors.affiliation: Division of HIV/AIDS disease, Puán 381, 2 piso, C1406CQG Buenos Aires, Argentina. marcelocorti@fibertel.com.ar
authors.forename: Marcelo
authors.initials: M
authors.lastname: Corti
authors.forename: Luis De
authors.initials: LD
authors.lastname: Carolis
authors.forename: Rubén
authors.initials: R
authors.lastname: Solari
authors.forename: María F
authors.initials: MF
authors.lastname: Villafañe
authors.forename: Ricardo
authors.initials: R
authors.lastname: Schtirbu
authors.forename: Daniel
authors.initials: D
authors.lastname: Lewi
authors.forename: Marina
authors.initials: M
authors.lastname: Narbaitz
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D016483:Lymphoma, AIDS-Related / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D008297:Male; D011241:Prednisone / Q000008:administration & dosage; D012189:Retrospective Studies; D012878:Skin Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone